stockscountryunited states index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  vicl stock price  vical inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states vicl overview compare quotes stock screener earnings calendar sectors nasdaq vicl us nasdaq join td ameritrade find a broker vical inc watchlist createviclalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones jc penney and more of the years most profitable shorts dec   at  pm et monday’s movers blackberry apple tesla aug   at  pm et by maria lamagna stock futures knocked by japan data taper fears aug   at  am et by william l watts vical shares plunge  premarket after drug trial aug   at  am et by saumya vaishampayan vical off nearly  on drug disappointment aug   at  am et by barbara kollmeyer stocks to watch friday analogic werner sep   at  pm et by david b wilkerson thursday’s biggest gaining and declining stocks sep   at  pm et by marketwatch friday’s biggest gaining and declining stocks jan   at  pm et by kate gibson vical slides  on stock offering jan   at  am et by val brickates kennedy friday’s biggest gaining and declining stocks jul   at  pm et by kate gibson vical jumps  on vaccine deal jul   at  pm et by val brickates kennedy google rallies after hours following results jul   at  pm et by carla mozee vical biosante boost drug sector feb   at  pm et by val brickates kennedy friday’s biggest gaining and declining stocks sep   at  pm et by marketwatch wednesday’s biggest gaining and declining stocks sep   at  pm et by marketwatch biogen idec and vical shares fall sep   at  am et by val brickates kennedy vical shares crushed by failed drug trial sep   at  am et by val brickates kennedy thursdays biggest gaining and declining stocks feb   at  pm et by marketwatch mondays biggest gaining and declining stocks dec   at  pm et by marketwatch vical compugen lead drug stocks north dec   at  pm et by val brickates kennedy stocks to watch darden m sonic jun   at  am et on the wall street journal vical’s herpes vaccine didn’t meet primary endpoint jun   at  pm et on the wall street journal stocks finish flat aug   at  pm et on the wall street journal stocks to watch blackberry vical steinway aug   at  am et on the wall street journal stocks to watch apple k pall corp sep   at  am et on the wall street journal satyam computer services vical biggest price decliners say vicl sep   at  pm et on the wall street journal istar financial vical biggest price decliners sfi vicl sep   at  pm et on the wall street journal istar financial vical biggest price decliners sfi vicl sep   at  pm et on the wall street journal biosante falls schnitzer sinks jun   at  pm et on the wall street journal new tack with birdflu vaccine jul   at  am et on the wall street journal harvest natural resources vical biggest price gainers hnr vicl jun   at  pm et on the wall street journal shares of some banks show weakness oct   at  am et on the wall street journal blue dolphin and epicept jump apr   at  am et on the wall street journal skyworks kopin zoran decline oct   at  am et on the wall street journal nih to launch study of aids vaccine oct   at  pm et on the wall street journal dnabased vaccines may help humans sep   at  am et on the wall street journal innogenetics carves out niche jul   at  am et on the wall street journal inputoutput superior energy rise feb   at  pm et on the wall street journal standard pacific beazer tumble jul   at  pm et on the wall street journal upgrades boost small caps jul   at  pm et on the wall street journal recent news other news press releases top analyst upgrades and downgrades adobe alibaba apple pandora vodafone cigna lexicon pharma and many more stocks were indicated to open slightly lower on monday after some of the top momentum and crowded technology companies took it on the chin on friday still a rotation took place into more stable names and into other sectors as the top market darlings slid this bull market is now over eight years old and   jun   at  am et on wallstcom premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha q vical inc q vical inc may   at  pm et on edgar online  edg  q k vicals vicl ceo vijay samant on q  results  earnings call transcript vicals vicl ceo vijay samant on q  results  earnings call transcript may   at  pm et on seeking alpha vical completes enrollment in midstage study of hsv vaccine apr   at  am et on seeking alpha premarket gainers as of  am apr   at  am et on seeking alpha vical inks hep b research deal with anges mg shares ahead  premarket apr   at  am et on seeking alpha vical vicl presents at th annual roth conference mar   at  pm et on seeking alpha k vical inc mar   at  pm et on edgar online  edg  q k vicals vicl ceo vijay samant on q  results  earnings call transcript mar   at  am et on seeking alpha is the big crash coming why the market continues to run mar   at  pm et on seeking alpha vical a risky netnet provides the potential for a profitable swing trade jan   at  am et on seeking alpha  biotechnology stocks to sell now nov   at  am et on investorplacecom  biotechnology stocks to sell now nov   at  am et on investorplacecom q vical inc nov   at  pm et on edgar online  edg  q k the best netnet stocks on wallstreet today nov   at  am et on seeking alpha vicals vicl ceo vijay samant on q  results  earnings call transcript nov   at  pm et on seeking alpha vical slumps cytomegalovirus vaccine fails in phase ii study sep   at  pm et on zackscom biotech forum daily digest fda finally caves on sarepta biotech rally continues spotlight on sage therapeutics sep   at  pm et on seeking alpha hottest manufacturing stocks now – srpt tanh sorl ptct sep   at  am et on investorplacecom vical to provide company update at the  bio international convention vical to provide company update at the  bio international convention jun   at  pm et on globenewswire vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  jun   at  am et on globenewswire vical to present vl data at the june asm microbe  meeting vical to present vl data at the june asm microbe  meeting may   at  am et on globenewswire investor network vical incorporated to host earnings call investor network vical incorporated to host earnings call may   at  am et on accesswire vical reports first quarter  financial results vical reports first quarter  financial results may   at  am et on globenewswire investor network invites you to the vical first quarter  earnings webcast live on monday may   investor network invites you to the vical first quarter  earnings webcast live on monday may   may   at  pm et on accesswire vical announces news release and conference call schedule for first quarter  financial results vical announces news release and conference call schedule for first quarter  financial results may   at  am et on globenewswire vical highlights successful outcome of phase  trial of vl novel antifungal during its research and development day vical highlights successful outcome of phase  trial of vl novel antifungal during its research and development day may   at  pm et on globenewswire vical to host virtual research  development day on may   apr   at  am et on globenewswire vical completes target enrollment in its phase  therapeutic hsv vaccine trial apr   at  am et on globenewswire vical to provide company update at the th annual roth conference mar   at  am et on globenewswire vical to provide company update at bio asia international conference mar   at  am et on globenewswire vical reports fourth quarter  financial results mar   at  am et on globenewswire investor network invites you to the vical fourth quarter  earnings webcast live on thursday march   mar   at  pm et on accesswire vical announces news release and conference call schedule for fourth quarter  financial results mar   at  am et on globenewswire vical provides company update at biocoms global life science partnering conference feb   at  pm et on globenewswire vical provides company update at bio ceo and investor conference feb   at  am et on globenewswire vical reports third quarter  financial results nov   at  am et on globenewswire investor calendar invites you to the vical third quarter  earnings webcast live on thursday november   nov   at  pm et on accesswire vical announces news release and conference call schedule for third quarter  financial results oct   at  am et on globenewswire vical inc vical inc is a biopharmaceutical company the company engages in the research and development of biopharmaceutical products based on patented dna delivery technologies for the prevention and treatment of serious or lifethreatening diseases its core technology involves the insertion of dna into plasmids designed to deliver the desired genes into cells in the body the companys pipeline consists of asp therapeutic cmv vaccine cymvectin prophylactic cmv vaccine and vl antifungal vical was founded by howard e greene jr timothy j wollaeger karl y hostetler and douglas d richman in april  and is headquartered in san diego ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations jul   at  am et on benzingacom competitors name chg  market cap celldex therapeutics inc  m bristolmyers squibb co  b pfizer inc  b sanofi adr  b merck  co inc  b competitor data provided by partner content trending tickers powered by dvax  s  ssti  mo  true  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience vicl stock price  vical inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p barrons buzz robo  facebook and twitter trading on news p a wild week in washington p updated the dark side of cruises p trump to police dont be too nice p updated the highest paid athletes in the world in one chart p updated oj simpson made over  while in prison and won’t have to give any of it to the goldman family p updated here are  coworkers you should avoid like the plague — especially in meetings p updated top  most annoying people you may want to unfriend on facebook p updated this is one person you should never unfriend on facebook to be replaced home investing quotes stocks united states vicl overview compare quotes stock screener earnings calendar sectors nasdaq vicl us nasdaq join td ameritrade find a broker vical inc watchlist createviclalert closed last updated jul    pm edt delayed quote     previous close  advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  k open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest k   of float shorted  average volume k performance  day   month   month  ytd   year  recent news marketwatch other dow jones jc penney and more of the years most profitable shorts dec   at  pm et monday’s movers blackberry apple tesla aug   at  pm et by maria lamagna stock futures knocked by japan data taper fears aug   at  am et by william l watts vical shares plunge  premarket after drug trial aug   at  am et by saumya vaishampayan vical off nearly  on drug disappointment aug   at  am et by barbara kollmeyer stocks to watch friday analogic werner sep   at  pm et by david b wilkerson thursday’s biggest gaining and declining stocks sep   at  pm et by marketwatch friday’s biggest gaining and declining stocks jan   at  pm et by kate gibson vical slides  on stock offering jan   at  am et by val brickates kennedy friday’s biggest gaining and declining stocks jul   at  pm et by kate gibson vical jumps  on vaccine deal jul   at  pm et by val brickates kennedy google rallies after hours following results jul   at  pm et by carla mozee vical biosante boost drug sector feb   at  pm et by val brickates kennedy friday’s biggest gaining and declining stocks sep   at  pm et by marketwatch wednesday’s biggest gaining and declining stocks sep   at  pm et by marketwatch biogen idec and vical shares fall sep   at  am et by val brickates kennedy vical shares crushed by failed drug trial sep   at  am et by val brickates kennedy thursdays biggest gaining and declining stocks feb   at  pm et by marketwatch mondays biggest gaining and declining stocks dec   at  pm et by marketwatch vical compugen lead drug stocks north dec   at  pm et by val brickates kennedy stocks to watch darden m sonic jun   at  am et on the wall street journal vical’s herpes vaccine didn’t meet primary endpoint jun   at  pm et on the wall street journal stocks finish flat aug   at  pm et on the wall street journal stocks to watch blackberry vical steinway aug   at  am et on the wall street journal stocks to watch apple k pall corp sep   at  am et on the wall street journal satyam computer services vical biggest price decliners say vicl sep   at  pm et on the wall street journal istar financial vical biggest price decliners sfi vicl sep   at  pm et on the wall street journal istar financial vical biggest price decliners sfi vicl sep   at  pm et on the wall street journal biosante falls schnitzer sinks jun   at  pm et on the wall street journal new tack with birdflu vaccine jul   at  am et on the wall street journal harvest natural resources vical biggest price gainers hnr vicl jun   at  pm et on the wall street journal shares of some banks show weakness oct   at  am et on the wall street journal blue dolphin and epicept jump apr   at  am et on the wall street journal skyworks kopin zoran decline oct   at  am et on the wall street journal nih to launch study of aids vaccine oct   at  pm et on the wall street journal dnabased vaccines may help humans sep   at  am et on the wall street journal innogenetics carves out niche jul   at  am et on the wall street journal inputoutput superior energy rise feb   at  pm et on the wall street journal standard pacific beazer tumble jul   at  pm et on the wall street journal upgrades boost small caps jul   at  pm et on the wall street journal recent news other news press releases top analyst upgrades and downgrades adobe alibaba apple pandora vodafone cigna lexicon pharma and many more stocks were indicated to open slightly lower on monday after some of the top momentum and crowded technology companies took it on the chin on friday still a rotation took place into more stable names and into other sectors as the top market darlings slid this bull market is now over eight years old and   jun   at  am et on wallstcom premarket analyst action  healthcare premarket analyst action  healthcare jun   at  am et on seeking alpha q vical inc q vical inc may   at  pm et on edgar online  edg  q k vicals vicl ceo vijay samant on q  results  earnings call transcript vicals vicl ceo vijay samant on q  results  earnings call transcript may   at  pm et on seeking alpha vical completes enrollment in midstage study of hsv vaccine apr   at  am et on seeking alpha premarket gainers as of  am apr   at  am et on seeking alpha vical inks hep b research deal with anges mg shares ahead  premarket apr   at  am et on seeking alpha vical vicl presents at th annual roth conference mar   at  pm et on seeking alpha k vical inc mar   at  pm et on edgar online  edg  q k vicals vicl ceo vijay samant on q  results  earnings call transcript mar   at  am et on seeking alpha is the big crash coming why the market continues to run mar   at  pm et on seeking alpha vical a risky netnet provides the potential for a profitable swing trade jan   at  am et on seeking alpha  biotechnology stocks to sell now nov   at  am et on investorplacecom  biotechnology stocks to sell now nov   at  am et on investorplacecom q vical inc nov   at  pm et on edgar online  edg  q k the best netnet stocks on wallstreet today nov   at  am et on seeking alpha vicals vicl ceo vijay samant on q  results  earnings call transcript nov   at  pm et on seeking alpha vical slumps cytomegalovirus vaccine fails in phase ii study sep   at  pm et on zackscom biotech forum daily digest fda finally caves on sarepta biotech rally continues spotlight on sage therapeutics sep   at  pm et on seeking alpha hottest manufacturing stocks now – srpt tanh sorl ptct sep   at  am et on investorplacecom vical to provide company update at the  bio international convention vical to provide company update at the  bio international convention jun   at  pm et on globenewswire vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  jun   at  am et on globenewswire vical to present vl data at the june asm microbe  meeting vical to present vl data at the june asm microbe  meeting may   at  am et on globenewswire investor network vical incorporated to host earnings call investor network vical incorporated to host earnings call may   at  am et on accesswire vical reports first quarter  financial results vical reports first quarter  financial results may   at  am et on globenewswire investor network invites you to the vical first quarter  earnings webcast live on monday may   investor network invites you to the vical first quarter  earnings webcast live on monday may   may   at  pm et on accesswire vical announces news release and conference call schedule for first quarter  financial results vical announces news release and conference call schedule for first quarter  financial results may   at  am et on globenewswire vical highlights successful outcome of phase  trial of vl novel antifungal during its research and development day vical highlights successful outcome of phase  trial of vl novel antifungal during its research and development day may   at  pm et on globenewswire vical to host virtual research  development day on may   apr   at  am et on globenewswire vical completes target enrollment in its phase  therapeutic hsv vaccine trial apr   at  am et on globenewswire vical to provide company update at the th annual roth conference mar   at  am et on globenewswire vical to provide company update at bio asia international conference mar   at  am et on globenewswire vical reports fourth quarter  financial results mar   at  am et on globenewswire investor network invites you to the vical fourth quarter  earnings webcast live on thursday march   mar   at  pm et on accesswire vical announces news release and conference call schedule for fourth quarter  financial results mar   at  am et on globenewswire vical provides company update at biocoms global life science partnering conference feb   at  pm et on globenewswire vical provides company update at bio ceo and investor conference feb   at  am et on globenewswire vical reports third quarter  financial results nov   at  am et on globenewswire investor calendar invites you to the vical third quarter  earnings webcast live on thursday november   nov   at  pm et on accesswire vical announces news release and conference call schedule for third quarter  financial results oct   at  am et on globenewswire vical inc vical inc is a biopharmaceutical company the company engages in the research and development of biopharmaceutical products based on patented dna delivery technologies for the prevention and treatment of serious or lifethreatening diseases its core technology involves the insertion of dna into plasmids designed to deliver the desired genes into cells in the body the companys pipeline consists of asp therapeutic cmv vaccine cymvectin prophylactic cmv vaccine and vl antifungal vical was founded by howard e greene jr timothy j wollaeger karl y hostetler and douglas d richman in april  and is headquartered in san diego ca see full profile analyst ratings sell under hold over buy number of ratings  full ratings benzingas top initiations jul   at  am et on benzingacom competitors name chg  market cap celldex therapeutics inc  m bristolmyers squibb co  b pfizer inc  b sanofi adr  b merck  co inc  b competitor data provided by partner content trending tickers powered by dvax  s  ssti  mo  true  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience bing places for business bing places for business sign in using your microsoft account work account google account facebook account dont have an account create one stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stocks index  markets index bulletin investor alert stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice    viclnasdaq cm stock quote  vical inc  bloomberg markets error could not add to watchlist x  watchlist vical inc viclus nasdaq cm usd   as of  pm edt  open  day range    volume  previous close  wk range     yr return  before its here its on the bloomberg terminal learn more open  day range    volume  previous close  wk range     yr return  ytd return  current pe ratio ttm  earnings per share usd ttm  market cap m usd  shares outstanding m  pricesales ttm  dividend indicated gross yield  sector health care  price change  industry pharmaceuticals biotechnology  life sciences  price change  related videos there are currently no related videos for this ticker please check back later company news press releases there are currently no news stories for this ticker please check back later  vical to provide company update at the  bio international convention  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase   aspergillosis pipeline market global analysis and therapeutics development h  report now available at  vical to present vl data at the june asm microbe  meeting  vical reports first quarter  financial results  vical announces news release and conference call schedule for first quarter  financial results  vical highlights successful outcome of phase  trial of vl novel antifungal during its research and development day  richard kenney md facp joins tapimmune to lead the clinical development program  vical to host virtual research  development day on may    vical completes target enrollment in its phase  therapeutic hsv vaccine trial there are currently no press releases for this ticker please check back later profile vical incorporated develops genebased pharmaceutical products for human therapy the company develops cancer product candidates as well as develops vaccines for infectious diseases and genebased delivery of therapeutic proteins for other disorders address  pacific center courtsan diego ca united states phone  website wwwvicalcom executives board members vijay b samant presidentceo anthony a ramos cfochief acctg officer mammen p mammen senior vpclinical development larry r smith senior vpresearch keith d hall vpoperations show more vicl  stock quote for vical inc  msn money msn back to msn home money web search sign in change language  content américa latina español argentina español australia english belgië nederlands belgique français brasil português canada english canada français chile español colombia español danmark dansk deutschland deutsch españa español france français india english indonesia bahasa indonesia ireland english italia italiano malaysia english méxico español nederland nederlands new zealand english norge norsk bokmål österreich deutsch perú español philippines english polska polski portugal português schweiz deutsch singapore english south africa english suisse français suomi suomi sverige svenska türkiye türkçe united arab emirates english united kingdom english united states english united states español venezuela español việt nam tiếng việt ελλάδα ελληνικά россия pусский ישראל עברית‏ الإمارات العربية المتحدة العربية‏ المملكة العربية السعودية العربية‏ مصر العربية‏ ไทย ไทย 한국 한국어      語   switch to latino español feedback help adchoices vical inc nasdaq vicl us markets closed adchoices  ▼   after hours     july    pm edt delayed  minutes source nasdaq currency in usd save summary financials analysis options ownership company history related open  previous close  volume avg k k days range  wk range  market cap m dividend rate  yield  beta  shares outstanding m pe ratio eps  recent news melanoma drugs market industry overview and key factors openprcom  days ago somewhat positive news coverage very likely to affect vical vicl share price breeze  somewhat favorable media coverage very likely to affect vical vicl share price breeze  negative press coverage extremely likely to affect vical nasdaqvicl stock price bns  vical vicl reaches  after  down move wintrust financial wtfc had  bulls thorold news  vical vicl given coverage optimism rating of  themarketsdailycom  hc wainwright analysts give vical incorporated vicl a  price target bns  vical to provide company update at the  bio international convention einpresswirecom  vical inc nasdaqvicl rating reaffirmed presstelegraphcom  hc wainwright reiterates a buy rating on vical inc marketsco  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  pipelinereviewcom  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  tmcnetcom  briefvical presents phase  vl data at june asm microbe  meeting supporting advancement to phase  business insider  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  globenewswire  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  nasdaq  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  benzinga  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  wwwpmonlinecom  vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  militarytechnologiesnet  adchoices adchoices adchoices markets dow dow ▲    last updated time   pm edt markets nasdaq nasdaq ▼    ftse  ftse  ▼    nyse composite nyse composite ▼    adchoices feedback send feedback provide feedback report a problem we appreciate your input select a category im having problems with top destinations im having issues searching im having problems with featured apps i see an error in the content other how we can improve please give an overall site rating submit close privacy statement help help  support vical inc executives organizational chart company profile information contacts  headquarters locations news submit contactcareerslogin menutoggle our difference research client successwho we serve sales professionals marketing professionals executives recruitingstaffing professionalssolutions column abm  abs actionable intelligence competitive intelligence customer success  retention column data quality  management data sets integrations lead generation column predictive analytics sales  marketing alignment targeting  ranking knowledge hub blog case studies insights faqsabout careers news pricing menu homeour difference research client successwho we serve sales professionals marketing professionals executives recruitingstaffing professionalssolutions abm  abs actionable intelligence competitive intelligence customer success  retention data quality  management data sets integrations lead generation predictive analytics sales  marketing alignment targeting  rankingknowledge hub blog case studies insights faqsabout careers news pricingget a free profileschedule a demorequest pricingcontact uslogin home  companies  vical inc vical inc  pacific center court san diego ca  united states phone   fax   httpwwwvicalcom  managers  it employees mest it budget vical inc develops technology using dna for the prevention and treatment of serious or lifethreatening diseases it is headquartered in san diego ca and was founded in  sector industry healthcare  pharmaceuticals biotech and pharmaceuticals employees  revenue m fye  breaking news on investment signals date type inside scoop want full access to this profile and more rainkings clients have access to over  new investment signals published daily which provide insights on spending initiatives pain points management changes and more from companies around the globe interested in becoming a client request a demo request a quote technologies currently being used it marketing data analytics databases relational databases microsoft access web analytics comscorecross pixeldatalogixgoogle analytics gagoogle universal analyticslotameowneriq data infrastructure cloud systems citrix netscaler email hosting mimecast mail server hosting intermediaprolexic technologies hosting data storage storage management iron mountain enterprise erp enterprise resource planning erp solarsoft hris ceridian industry software professional services software aggregate knowledgedstilleryquickbooks this is just a subset of the full technolgies being used by this company analytics web analytics google universal analytics creative content website design linkedinbutton ecommerce social commerce prolexic technologies hosting product brand mgmt mobile application and content services twitter sales mktg automation email marketing mimecast mail server this is just a subset of the full technolgies being used by this company become a rainking poweruser today rainkings rich data provides clients with a deeper understanding of who will be making – and what will be driving – upcoming investments in it know what your prospects are planning before your competition does and beat them to the negotiating table request a demo request a quote org chart of it decision makers nathan sampson manager information technology vicalcom   anthony ramos vice president finance and chief accounting officer vicalcom   larry smith vice president vaccine research vicalcom   this is just a subset of the full org chart for this company want access to this and more become a client today rainking clients get access to all  decision makers in this companys org chart request a demo request a quote want full access to this profile and more rainkings clients have access to over  new investment signals published daily which provide insights on spending initiatives pain points management changes and more from companies around the globe interested in becoming a client request a demo request a quote to receive a free pdf of this company simply fill out the form below get your free company profile search subscribe to our newsletter connect with us  old georgetown road bethesda md   contactusrainkingonlinecom sitemap terms of use privacy policy  rainking vical incorporated  product pipeline review      about us blog contact us faq  usd eur gbp usd ▼ usd eur gbp € eur  usd £ gbp rest of world us toll free  advanced price from €eurusd£gbp view pricing home  categories  company reports select a format  €eurusd£gbp single user electronic pdf  this is a single user license allowing one specific user access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp site license electronic pdf  this is a site license allowing all users within a given geographical location of your organisation access to the product the report will be emailed to you the report is sent in pdf format  €eurusd£gbp enterprisewide electronic pdf  this is an enterprise license allowing all employees within your organisation access to the product the report will be emailed to you the report is sent in pdf format  add to basket order by fax need a quote  our clients have a question email us view faqs recently viewed products partner of research and marketsvaccinating  children in  why choose research and markets worlds largest selection trusted by the best customer focused safe  secure this the second time my company ordered reports from research and markets the customer team responded very fast and communication was excellent read more samuel tanudjaya assistant manager pt synco global vical incorporated  product pipeline review   id  company profile july   pages global markets direct vical inc description table of contents samples formats  of  login to access executive summary printer friendly printable pdf brochure send to a friend vical incorporated  product pipeline review  summarythis ‘vical incorporated  product pipeline review  ’ provides an overview of the vical incorporated’s pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of vical incorporated’s complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsthis report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from this proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by this team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of vical incorporated including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of vical incorporated’s human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement latest news and deals relating to the vical incorporated’s pipeline productsreasons to buy evaluate vical incorporated’s strategic position with total access to detailed information on its product pipeline assess the growth potential of vical incorporated in its therapy areas of focus identify new drug targets and therapeutic classes in the vical incorporated’s rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of vical incorporated and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of vical incorporated develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of vical incorporated and identify potential opportunities in those areas avoid intellectual property rights related issues show less read more note product cover images may vary from those shown  of  login to access executive summary printer friendly printable pdf brochure send to a friend list of tableslist of figuresvical incorporated snapshotvical incorporated overviewkey informationkey factsvical incorporated  research and development overviewkey therapeutic areasvical incorporated  pipeline reviewpipeline products by stage of developmentpipeline products  monotherapypipeline products  partnered productspartnered productscombination treatment modalitiespipeline products  outlicensed productsoutlicensed productscombination treatment modalitiesvical incorporated  pipeline products glancevical incorporated  clinical stage pipeline productsphase i productscombination treatment modalitiesvical incorporated  early stage pipeline productsindcta filed productscombination treatment modalitiespreclinical productscombination treatment modalitiesvical incorporated  drug profilesvclhbproduct descriptionmechanism of actionrd progressvclhmproduct descriptionmechanism of actionrd progresscymvectinproduct descriptionmechanism of actionrd progressaspproduct descriptionmechanism of actionrd progressmeasles bivalent vaccineproduct descriptionmechanism of actionrd progressvical incorporated  pipeline analysisvical incorporated  pipeline products by targetvical incorporated  pipeline products by route of administrationvical incorporated  pipeline products by molecule typevical incorporated  recent pipeline updatesvical incorporated  dormant projectsvical incorporated  discontinued pipeline productsdiscontinued pipeline product profileshiv vaccinevical incorporated  company statementvical incorporated  locations and subsidiarieshead officeappendixmethodologycoveragesecondary researchprimary researchexpert panel validationcontact usdisclaimer list of tablesvical incorporated key informationvical incorporated key factsvical incorporated  pipeline by indication vical incorporated  pipeline by stage of development vical incorporated  monotherapy products in pipeline vical incorporated  partnered products in pipeline vical incorporated  partnered products combination treatment modalities vical incorporated  outlicensed products in pipeline vical incorporated  outlicensed products combination treatment modalities vical incorporated  phase i vical incorporated  indcta filed vical incorporated  preclinical vical incorporated  pipeline by target vical incorporated  pipeline by route of administration vical incorporated  pipeline by molecule type vical incorporated  recent pipeline updates vical incorporated  dormant developmental projectsvical incorporated  discontinued pipeline products  list of figuresvical incorporated  pipeline by top  indication vical incorporated  pipeline by stage of development vical incorporated  monotherapy products in pipeline vical incorporated  partnered products in pipeline vical incorporated  pipeline by top  target vical incorporated  pipeline by top  molecule type  note product cover images may vary from those shown  of  loading  of  note product cover images may vary from those shown related products vical inc vicl  financial and strategic swot analysis review  swot analysis june  from €eurusd£gbp corcept therapeutics incorporated  product pipeline review    company profile may  from €eurusd£gbp vertex pharmaceuticals incorporated  product pipeline review    company profile april  from €eurusd£gbp vertex pharmaceuticals incorporated  product pipeline review    company profile march  from €eurusd£gbp insite vision incorporated  product pipeline review    company profile june  from €eurusd£gbp sbio inc  product pipeline review    company profile september  from €eurusd£gbp agenus inc  product pipeline review    company profile april  from €eurusd£gbp vernalis plc  product pipeline review    company profile december  from €eurusd£gbp allergan plc  product pipeline review    company profile march  from €eurusd£gbp actavis plc  product pipeline review    company profile may  from €eurusd£gbp close vical incorporated  product pipeline review   close ask a question required information product vical incorporated  product pipeline review   your question your contact details title mr mrs dr miss ms prof first name last name email address country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe phone number                                                                                                                                                                                                                                    we request your telephone number so we can contact you in the event we have difficulty reaching you via email we aim to respond to all questions on the same business day close send to a friend  required information friends details full name email address message to friend your contact details full name email address close request a quote please complete the below form and click send request to obtain a pdf quotation and order form this document will be available for immediate download and will also be emailed to you  required information your address address  address  address  city postalzip code country please select  united states united kingdom germany canada australia  afghanistan albania algeria american samoa andorra angola anguilla antarcticacasey antarcticascott antigua and barbuda argentina armenia aruba ascension island ashmore and cartier islands atlantic east atlantic west australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil british virgin islands brunei bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china christmas island clipperton island cocos keeling islands colombia comoros congo cook islands costa rica croatia cuba curaco cyprus czech republic democratic republic of congo denmark djibouti dominica dominican republic east timor ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands islas malvinas faroe islands fiji islands finland france french guiana french polynesia gabon gambia gaza strip georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guineabissau guyana haiti honduras hong kong hungary iceland india indonesia iran iraq ireland israel italy ivory coast ivory coast cote divoire jamaica japan jordan kazakhstan kenya kiribati kosovo kuwait kyrgyzstan laos latvia lebanon lesotho liberia libya liechtenstein lithuania luxembourg macau macedonia madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte islands mexico micronesia moldova monaco mongolia montenegro montserrat morocco mozambique myanmar namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk islands north korea northern ireland northern marianas norway oman pakistan palau palestine panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar reunion romania russia rwanda saint christopher nevis saint helena saint kitts and nevis saint lucia saint martin saint vincent and the grenadines samoa san marino sao tome saudi arabia scotland senegal serbia serbia and montenegro seychelles sierra leone singapore sint maarten slovakia slovenia solomon islands somalia south africa south korea spain sri lanka sudan suriname swaziland sweden switzerland syria tahiti taiwan tajikistan tanzania thailand togo trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu vatican city holy see venezuela vietnam virgin islands wallis and futuna west bank west indies western sahara yemen yugoslavia zaire zambia zimbabwe state your details title mr mrs dr miss ms prof first name last name organisation email address phone number                                                                                                                                                                                                                                    po number if applicable product format license format properties price single user electronic pdf the report will be emailed to you the report is sent in pdf format this is a single user license allowing one specific user access to the product €eurusd£gbp site license electronic pdf the report will be emailed to you the report is sent in pdf format this is a site license allowing all users within a given geographical location of your organisation access to the product €eurusd£gbp enterprisewide electronic pdf the report will be emailed to you the report is sent in pdf format this is an enterprise license allowing all employees within your organisation access to the product €eurusd£gbp  the price quoted above is only valid for  days please submit your order within that time frame to avail of this price as all prices are subject to change vical  home about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    home vical develops biopharmaceutical products for the prevention and treatment of chronic or lifethreatening infectious diseases based on our patented dna delivery technologies and other therapeutic approaches latest view all news recent news june   vical to provide company update at the  bio international convention june   vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  latest events  presentations view all events  presentations june   vical provides company update at the  bio international convention view the webcast may   vical inc q financial results conference call view the webcast product pipeline about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vical  products  pipeline about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    products pipeline asp therapeutic cmv vaccine cymvectin™ prophylactic cmv vaccine vclhb therapeutic hsv vaccine vl antifungal other products apex®ihn dengue vaccine oncept® pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalapex®ihndengue vaccineoncept®other products home  products  pipeline   about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vical  home about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    home vical develops biopharmaceutical products for the prevention and treatment of chronic or lifethreatening infectious diseases based on our patented dna delivery technologies and other therapeutic approaches latest view all news recent news june   vical to provide company update at the  bio international convention june   vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase  latest events  presentations view all events  presentations june   vical provides company update at the  bio international convention view the webcast may   vical inc q financial results conference call view the webcast product pipeline about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vical  contact us  directions to vical about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    contact us contact info directions to vical careers contact infodirections to vicalcareers home  contact us  directions to vical directions to vical vical incorporated pacific center courtsan diego ca  view larger map about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vicl key statistics  vical inc financial ratios  marketwatch bulletin investor alert expand keep open close expand keep open close expand keep open close expand keep open close expand keep open close vical inc nasdaq vicl go set alerts find a broker join td ameritrade market index overview profile news charts financials historical quotes analyst estimates options sec filings insiders marketstatecountryus vical inc market closed  quotes are delayed by  min jul    pm vicl quoteszigmancomposite   change   volume volume  quotes are delayed by  min quoteszigmancomposite previous close     change   day low day high    week low  week high   company description vical inc is a biopharmaceutical company the company engages in the research and development of biopharmaceutical products based on patented dna delivery technologies for the prevention and treatment of serious or lifethreatening diseases its core technology involves the insertion of dna into p vical inc is a biopharmaceutical company the company engages in the research and development of biopharmaceutical products based on patented dna delivery technologies for the prevention and treatment of serious or lifethreatening diseases its core technology involves the insertion of dna into plasmids designed to deliver the desired genes into cells in the body the companys pipeline consists of asp therapeutic cmv vaccine cymvectin prophylactic cmv vaccine and vl antifungal vical was founded by howard e greene jr timothy j wollaeger karl y hostetler and douglas d richman in april  and is headquartered in san diego ca valuation pe current  pe ratio with extraordinary items  price to sales ratio  price to book ratio  enterprise value to ebitda  enterprise value to sales  efficiency revenueemployee  income per employee  total asset turnover  liquidity current ratio  quick ratio  cash ratio  profitability gross margin  operating margin  pretax margin  net margin  return on assets  return on equity  return on total capital  return on invested capital  capital structure officers and executives name age officer since title mr vijay b samant   president chief executive officer  director mr keith d hall   vice presidentoperations mr anthony alan ramos   chief financial  accounting officer dr lawrence russell smith   vice presidentvaccine research dr mammen p mammen   vice presidentclinical vaccines insider actions – purchase – sale  – number of transactions  newslatestcompanyusvicl marketwatch news on vicl jc penney and more of the years most profitable shorts  pm dec    blogsmarketwatchcom monday’s movers blackberry apple tesla  pm aug    maria lamagna stock futures knocked by japan data taper fears  am aug    william l watts vical shares plunge  premarket after drug trial  am aug    saumya vaishampayan vical off nearly  on drug disappointment  am aug    barbara kollmeyer stocks to watch friday analogic werner  pm sept    david b wilkerson thursday’s biggest gaining and declining stocks  pm sept    marketwatch friday’s biggest gaining and declining stocks  pm jan    kate gibson vical slides  on stock offering  pm jan    val brickates kennedy friday’s biggest gaining and declining stocks  pm july    kate gibson vical jumps  on vaccine deal  pm july    val brickates kennedy google rallies after hours following results  pm july    carla mozee vical biosante boost drug sector  pm feb    val brickates kennedy friday’s biggest gaining and declining stocks  pm sept    marketwatch wednesday’s biggest gaining and declining stocks  pm sept    marketwatch biogen idec and vical shares fall  am sept    val brickates kennedy vical shares crushed by failed drug trial  am sept    val brickates kennedy thursdays biggest gaining and declining stocks  pm feb    marketwatch mondays biggest gaining and declining stocks  pm dec    marketwatch vical compugen lead drug stocks north  pm dec    val brickates kennedy loading more headlines newsnonmarketwatchcompanyusvicl other news on vicl premarket analyst action  healthcare  am june    seeking alpha top analyst upgrades and downgrades adobe alibaba apple pandora vodafone cigna lexicon pharma and many more  am june    wallstcom q vical inc  pm may    edgar online  edg  q k vicals vicl ceo vijay samant on q  results  earnings call transcript  pm may    seeking alpha vical completes enrollment in midstage study of hsv vaccine  am april    seeking alpha premarket gainers as of  am  am april    seeking alpha vical inks hep b research deal with anges mg shares ahead  premarket  am april    seeking alpha vical vicl presents at th annual roth conference  pm march    seeking alpha k vical inc  pm march    edgar online  edg  q k vicals vicl ceo vijay samant on q  results  earnings call transcript  am march    seeking alpha is the big crash coming why the market continues to run  pm march    seeking alpha vical a risky netnet provides the potential for a profitable swing trade  pm jan    seeking alpha  biotechnology stocks to sell now  am nov    investorplacecom  biotechnology stocks to sell now  am nov    investorplacecom q vical inc  pm nov    edgar online  edg  q k the best netnet stocks on wallstreet today  am nov    seeking alpha vicals vicl ceo vijay samant on q  results  earnings call transcript  pm nov    seeking alpha vical slumps cytomegalovirus vaccine fails in phase ii study  pm sept    zackscom biotech forum daily digest fda finally caves on sarepta biotech rally continues spotlight on sage therapeutics  pm sept    seeking alpha hottest manufacturing stocks now – srpt tanh sorl ptct  am sept    investorplacecom loading more headlines at a glance vical inc  pacific center court san diego california  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue m net income m employees  annual report for vicl newspressreleasecompanyusvicl press releases on vicl vical to provide company update at the  bio international convention  pm june    globenewswire vical presents phase  vl data at the june asm microbe  meeting supporting advancement to phase   am june    globenewswire vical to present vl data at the june asm microbe  meeting  am may    globenewswire investor network vical incorporated to host earnings call  am may    accesswire vical reports first quarter  financial results  am may    globenewswire investor network invites you to the vical first quarter  earnings webcast live on monday may    pm may    accesswire vical announces news release and conference call schedule for first quarter  financial results  am may    globenewswire vical highlights successful outcome of phase  trial of vl novel antifungal during its research and development day  pm may    globenewswire vical to host virtual research  development day on may    am april    globenewswire vical completes target enrollment in its phase  therapeutic hsv vaccine trial  am april    globenewswire vical to provide company update at the th annual roth conference  am march    globenewswire vical to provide company update at bio asia international conference  am march    globenewswire vical reports fourth quarter  financial results  am march    globenewswire investor network invites you to the vical fourth quarter  earnings webcast live on thursday march    pm march    accesswire vical announces news release and conference call schedule for fourth quarter  financial results  am march    globenewswire vical provides company update at biocoms global life science partnering conference  pm feb    globenewswire vical provides company update at bio ceo and investor conference  am feb    globenewswire vical reports third quarter  financial results  am nov    globenewswire investor calendar invites you to the vical third quarter  earnings webcast live on thursday november    pm nov    accesswire vical announces news release and conference call schedule for third quarter  financial results  am oct    globenewswire loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite tlt quoteszigmancomposite jnug x powered by log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  vical inc  san diego  san diego county  pacific center cour company directory and business data solutions about kompass register login login × please fill in your login and password register login forgot your password  english contact kompass north america please contact one of our team of experts from monday to friday between am and pm or by email     contact us search across  million selected companies in more than  countries or all suppliers one company rechercher data access business solutions sales leads online promotion easybusiness easylist free guide  bb prospecting success kompasspublictenders credit card payment webinar digital solutions booster promotional solutions register your company see all business solutions videos  tutorials quizz easybusiness find the right sales leads with more than  million companies and  search criteria our global bb database easybusiness will help you find the right customer leads and marketing lists find out more  easylist need help with finding prospects easylist is our straightforward on demand tool designed to help you build personalised company lists from a global database of  million companies find out more register your company build your free company profile if you are looking to expand into new markets or want to grow your sales activity then register your company free of charge on the global kompass bb directory find out more  booster engage your target audience engage your target audience and attract new business leads using the kompasscom our global online digital directory with over m visitors per month from  countries worldwide let us improve your seo and increase your customer traffic find out more  promotional solutions attract relevant enquiries build enhance and manage your company profile to attract visitors instantly use our ppc experts to help drive relevant enquiries through to your profile – cost effective managed and guaranteed find out more  free guide bb prospecting success best strategy to find targeted leads and drive great sales results publictenders publictenders public tenders payment portal payment portal credit card payment portal webinar skyrocketing your government contracting public tenders webinar learn about the value of selling to the us government key market challenges and how to find and respond to opportunities throughout the usa  plus get three months free access to the database california san diego county vical inc x every month we have millions of visitors on kompass looking for companies like yours register your company on kompass and build your free company profile to attract those visitors register login login vical inc  pacific center court san diego ca  united states need to contact this company call click to see their phone number call click to see their phone number  service   call price  this phone number available for  min is not the recipients number but a number from a service which will put you through to that person this service is produced by kompass  why this number  service  free calls  this number only available  minutes is not your correspondants number but the number of a service putting you through to that person this service is produced by kompass  why this number  all the lines are busy at the moment please try again in a moment view map location view their website purchase online company lists of companies create your prospect list  vical inc × addresses of  vical inc × description key figures executives activities description key figures executives activities company summary vical incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid dna delivery technologies for the prevention and treatment of serious or lifethreatening diseases in addition the company has gained access to enhancing technologies through licensing and collaborative agreements vical together with its licensees and collaborators is developing a number of dnabased vaccines and therapeutics for the prevention or treatment of infectious diseases cardiovascular diseases and cancer as of december   the companys independent development focus is on its novel plasmids pdna vaccines for cytomegalovirus cmv and avian influenza as well as its cancer immunotherapeutic il ep all of vicals potential products are in research and development phases no revenues have been generated from the sale of any such products vical inc is a biopharmaceutical firm that develops vaccines for the prevention and treatment of viruses and various forms of cancer based on its dna delivery technology general information year established  type of company head office fax    fps website httpwwwvicalcom key figures employees company  employees turnover   to  million usd executives executive information download the executives list jill church chief financial officer r d chairman emeritus v s president president ceo and director r j senior vice president svp business operations a r senior vice president v s president and chief executive officer a r executive vice president  product development i b senior vice president  corporate development l s vice president vaccine research r k md vice president clinical development j b chief financial officer senior vice president secretary senior vice president chief financial officer and  s p vice president purchasing e d directorengineering l s executive director for oncology clinical operations r t associate director quality control s s executive director pharmaceutical sciences l s associate director project planning and management k h manager d m quality assurance specialist h b manager g c senior director quality assurance j c clinical research associate j m manager s d manager r k manager t r controller c f manager s r manager w w eh and s manager g p financial compliance manager j m quality control t m research scientist m s associate director regulatory affairs m w research manager d b manager a c manager c b inventory m s clinical research  r account manager s b information technology staff j d manager r b associate manager j b finance d m mammen jr p a lalor activities activities producer distributor service provider honey products propolis barbiturates sulphonamides glycosides alkaloids and antibiotics carbohydrates proteins and enzymes coenzyme q pharmaceutical preparations for the central and autonomic nervous system and anaesthetics anaesthetics basal anaesthetics inhalation anaesthetics intravenous iv anaesthetics spinal anaesthetics local anaesthetic ether anaesthetic chloroform analeptics analgesics antialzheimer agents anticholinergics anticonvulsants antiepileptics antiinflammatory preparationsantiphlogistics antiinflammatories nonsteroidal antineuralgics antiparkinson agents antipyretics antiarthritics antirheumatic preparations hematoporphyrin and preparations stimulants and antidepressive agents for the central nervous system hypnotics opiates sedatives and tranquillisers psychotropic products muscle relaxants and their antagonists phenylisopropylamine and salts amphetamine sympatholytics parasympathomimetics sympathomimetics calcium antagonists neurological preparations pharmaceutical preparations for the cardiovascular system blood coagulants and haemostatics anticoagulants for blood antithrombins blood decompressants haemopoietics cardioaccelerators cardioregulators pharmaceutical cardiovascular products cardiotonics antiarrhythmic preparations angiotonics coronary vasodilators peripheral vasodilators antivaricose preparations hypertensive agents hypotensive agents pharmaceutical preparations for ear nose and throat ent and dentistry aural preparations oropharyngeal preparations nasopharyngeal preparations nasal creams nasal sprays throat sprays mouthwashes and throat washes pharmaceutical dental preparations pharmaceutical preparations for ophthalmology eye ointments eyedrops collyriums pharmaceutical ophthalmic preparations mydriatic eyewashes pharmaceutical steroid preparations for ophthalmic use ophthalmic preparations nes pharmaceutical preparations for metabolism nutrition alimentary systems antidismetabolics antiobesity preparations anorectics antianaemics bile and bile salt preparations cholesterol reducing agents appetite stimulants foods and nutrients herbal extracts dietary eutrophics pharmaceutical preparations for metabolism nes antidiabetic pharmaceuticals anabolic agents ferritin iron preparations medical pharmaceutical preparations for dermatology dermatological fungicides and keratolytics dermatological ointments and shampoos dermatological sedatives local keratolytics dermatological stimulants antipruritics calamine lotion creams nappy rash prevention antiacne preparations steroid preparations for dermatological use antipsoriatics antiburn preparations creams chilblain prevention lip balm lipsalve medicated wart removing preparations corn removing preparations pharmaceutical preparations for urology gynaecology and obstetrics contraceptive agents chemical galactagogues galactophores milk secretion stimulants pharmaceutical emmenagogues vaginal preparations nes pharmaceuticals gynaecological and obstetrical nes diuretics antidiuretics antienuretics antiurics uricosuric agents pharmaceuticals for urinary tract disorders nes pharmaceuticals for renal disorders antiprostatics erectile dysfunction drugs pharmaceutical preparations for pneumology catarrh preparations cough syrups respiratory stimulants asthma preparations cigarettes medical for asthmatics bronchodilators chemotherapeutic preparations gastroenterology and hepatology preparations antacids and preparations for gastric ulcers antidiarrhoeal preparations carminatives cholagogues choleretics hepatoprotectors hepatic products laxatives and purgatives laxatives fig based digestives eupeptics stomachics emetics antiemetics and antinauseants enema fluids antilithiasis products omeprazole pharmaceuticals for gastrointestinal disorders nes immunological preparations antiseptics and antibacterial preparations skin and wound disinfectants surgical spirit pharmaceutical preparations nes biopharmaceuticals pharmaceutical preparations vegetable based pharmaceutical preparations generic radiopharmaceutical products electrode creams and gels diaphoretics antiallergic preparations and antihistamines anhidrotics allergens for diagnostic and desensitisation purposes diagnostic kits medical biochemical diagnostic aids and tests nes surgical glue haemostatic sponges collagen oils and liquid paraffin for pharmaceuticals fish oils and fish oil extracts for medical use colourants edible for pharmaceuticals flavourings for pharmaceuticals emulsifying agents for pharmaceuticals solvents for pharmaceuticals balsams natural and synthetic for pharmaceuticals petrolatumpetroleum jelly vaseline for pharmaceuticals pharmaceutical excipients electrolytes intravenous iv application plasma substitutes dialysis fluids ointment bases for pharmaceuticals coal tar bases antiseptic and disinfectant glucose solution pharmaceutical infusion solutions subcutaneous and intravenous iv solutions for haemodialysis capsules gelatine for pharmaceuticals capsules soft vegetable starch based for pharmaceuticals collodions for pharmaceutical use sequestering agents for pharmaceuticals microcrystalline cellulose for pharmaceuticals cinchophen guaiaphenesin chondroitin sulphate capsules methylcellulose for pharmaceuticals plasters medical liquid medicinal pastilles and lozenges emulsions pharmaceutical oils medicated powders medicated tablets effervescent pharmaceutical to customer specification parapharmaceutical preparations cough preparations parapharmaceutical inhalants parapharmaceutical blood tonics parapharmaceutical nerve tonics parapharmaceutical melissa cordials tonic preparations for sportsmen depuratives parapharmaceutical cod liver oil and halibut oil preparations salt tablets medicinal nicotine replacement therapy products antitravel sickness tablets haemorrhoidal preparations slimming preparations parapharmaceutical cicatrizants liniments embrocations emollients parapharmaceutical medicated pencils or sticks insect repellents parapharmaceutical insectbite lotions jellyfish repellents parapharmaceutical tinctures pharmaceutical poultices mud bath preparations earplugs wax solvents adhesive plaster removing solutions contact lens cleaning shark cartilage products parapharmaceutical dietary supplements mineral or vitamin based parapharmaceutical products dead sea minerals based aromatherapy preparations herb or grain filled cushions herbal preparations medicinal herbs and infusions homeopathic preparations emu oil products parapharmaceutical gynaecological and obstetrical equipment test kits pregnancy textile articles for medical and surgical use research general other classifications for some countries sic us   biological products except diagnostic substances  naics us   biological product except diagnostic manufacturing  you might also like contact vical inc call click to see their phone number call click to see their phone number  service   call price  this phone number available for  min is not the recipients number but a number from a service which will put you through to that person this service is produced by kompass  why this number  service  free calls  this number only available  minutes is not your correspondants number but the number of a service putting you through to that person this service is produced by kompass  why this number  all the lines are busy at the moment please try again in a moment you might also like suneva medical inc   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics botanical laboratories   ferndale pharmaceutical preparations for the central and autonomic nervous system and anaesthetics isis pharmaceuticals inc   carlsbad pharmaceutical preparations for the central and autonomic nervous system and anaesthetics corvas international inc   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics bio cryst pharmaceuticals   hoover pharmaceutical preparations for the central and autonomic nervous system and anaesthetics neurocrine biosciences in   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics ligand pharmaceuticals in   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics holliseden pharmaceutica   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics imagenetix inc new   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics anadys pharmaceuticals in   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics axonyx inc   la jolla pharmaceutical preparations for the central and autonomic nervous system and anaesthetics favrille inc   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics immune response corp   carlsbad pharmaceutical preparations for the central and autonomic nervous system and anaesthetics mckenna labs inc   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics scweizerhall greenville   greenville pharmaceutical preparations for the central and autonomic nervous system and anaesthetics adp   birmingham pharmaceutical preparations for the central and autonomic nervous system and anaesthetics alliance pharmaceutical c   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics vyrex corp   la jolla pharmaceutical preparations for the central and autonomic nervous system and anaesthetics illumina inc   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics protein polymer technolog   san diego pharmaceutical preparations for the central and autonomic nervous system and anaesthetics our business solutions with kompass  global presence in more than  countries detailed and up to date company information comprehensive and filtered company directory frequent updates ensuring high quality data secure online payment help with expert advice dedicated customer service team contact kompass north america contact us vical  investors  stock information about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    investors overview stock information news releases events  presentations sec filings overviewstock informationnews releasesevents  presentationssec filings home  investors  stock information stock quote nasdaq gm nasd  vicl stock quote nasd price  change  volume   change  intraday high   week high  intraday low   week low  todays open  previous close  july    pm pricing delayed  minutes historical stock quote lookup date   jan feb mar apr may jun jul aug sep oct nov dec                                                                     high  low  volume  opening price  last  no data returned for  please select another date connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube irs form  about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vical  products  pipeline about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    products pipeline asp therapeutic cmv vaccine cymvectin™ prophylactic cmv vaccine vclhb therapeutic hsv vaccine vl antifungal other products apex®ihn dengue vaccine oncept® pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalapex®ihndengue vaccineoncept®other products home  products  pipeline   about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vical  about us  management about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    about us overview corporate governance board of directors board committees management careers overviewcorporate governanceboard committeesboard of directorsmanagementcareers home  about us  management management vijay b samant president and chief executive officer vijay b samant joined us as president and chief executive officer in november  mr samant has  years of diverse us and international sales marketing operations and business development experience with merck from  to mid he was chief operating officer of the merck vaccine division from  to  he served in the merck manufacturing division as vice president of vaccine operations vice president of business affairs and executive director of materials management mr samant earned a masters degree in management studies from the sloan school of management at the massachusetts institute of technology in  he received a masters degree in chemical engineering from columbia university in  and a bachelors degree in chemical engineering from the university of bombay university department of chemical technology in  mr samant presently serves as a member of the board of directors of ampliphi biosciences corporation mr samant was a member of the board of directors for raptor pharmaceutical from  to  and was a member of the board of directors for biomarin pharmaceutical from  to  mr samant was a director of the aeras global tb vaccine foundation rockville md from  to  a member of the board of trustees for the national foundation for infectious diseases nfid bethesda md from  to  and a member of the board of trustees for the international vaccine institute ivi seoul korea from  to  mammen p anza mammen jr md senior vice president clinical development mammen p “anza” mammen jr md joined us as vice president clinical vaccines in november  and was named senior vice president clinical development in may  prior to joining vical dr mammen retired as a colonel after a year career in the army medical corps most recently as infectious disease consultant and chief pandemic warning team us department of defense from  to  he served as the army’s product manager for vaccines in advanced development against dengue hepatitis e and hiv viruses for the us army medical research and materiel command usamrmc he was chief department of virology the armed forces research institute of medical sciences afrims thailand from  to  when he managed us food and drug administrationregulated vaccine field studies his previous assignments include serving as infectious disease officer walter reed army institute of research wrair and chief internal medicine clinic st general hospital seoul south korea dr mammen received his md degree from the pennsylvania state university college of medicine and is boardcertified in infectious diseases he has been elected as fellow by the infectious disease society of america idsa and the american college of physicians acp he received his internal medicine and infectious disease clinical training from the walter reed army medical center he earned a ba degree in mathematics from williams college larry r smith phd senior vice president research larry r smith phd joined us as executive director vaccinology in september  and was named senior vice president research in may  dr smith was director of viral vaccines research at wyeth vaccines where he oversaw the immunogenicity testing of various viral vaccines including a number of recombinant viral vectors prior to joining wyeth in  dr smith was a scientific investigator at immune response corporation where he identified autoreactive t cell targets in psoriasis and multiple sclerosis which led to the clinical testing of several therapeutic vaccine candidates dr smith received a bs degree in biology from purdue university a phd in microbiology and immunology from the university of texas medical branch and was a postdoctoral fellow in the immunology department at scripps clinic and research foundation anthony a ramos chief financial officer anthony a ramos joined us as corporate controller in february  and was named chief financial officer in may  from january  until joining vical mr ramos held various positions at copper mountain networks inc a publicly held network communications company most recently as vice president of finance with broad responsibilities in finance accounting treasury risk management and corporate governance from april  until joining copper mountain networks inc mr ramos was accounting manager at viasat inc a publicly held digital communications company where he held accounting and financial reporting responsibilities from january  until joining viasat inc mr ramos served as an audit manager at pricewaterhousecoopers llp where his clients included life sciences computer software and telecommunications companies as well as government contractors mr ramos received his bachelor’s degree in business administration and accounting from san diego state university and is a certified public accountant keith d hall vice president operations keith d hall joined us as director quality control and assay development in february  and was named vice president operations in april  mr hall has  years of biopharmaceutical experience including manufacturing process development assay development and quality from  to  he served as director of manufacturing for agennix in houston tx where he oversaw drug substance and product manufacture and the design construction and commissioning of a recombinant human lactoferrin bulk drug substance manufacturing facility in italy from  to  he served as senior manager quality control and analytical development for valentisgenemedicine in the woodlands tx prior to  mr hall served in various development and manufacturing positions of increasing responsibilities at hybritech and amgen he earned a master’s degree in business administration from the ct bauer college of business at the university of houston and a bachelor’s degree in microbiology from the university of california at santa barbara about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites vical  technology  publications about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers   nasdaq  vicl    technology dna technology poloxamer delivery system vaxfectin® adjuvant publications poloxamer delivery systemdna technologyvaxfectin® adjuvantpublications home  technology  publications publications                               bilinsky ip and smith lr questionnaire for biotechs vical incorporated hum vaccin immunother  dec doi   smith lr et al clinical development of a cytomegalovirus dna vaccine from product concept to pivotal phase  trial vaccines  sep doi vaccines kulkarni v et al vaccination with vaxfectin adjuvanted siv dna induces longlasting humoral immune responses able to reduce sivmac viremia hum vaccin immunother  jul  doi hv bilinsky ip and smith lr preclinical evaluation of vaxfectin®adjuvanted vero cellderived seasonal split and pandemic whole virus influenza vaccines hum vaccin immunother  jun  doi hv lin wh et al vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a dna vaccine encoding the measles virus hemagglutinin and fusion proteins j virol  jun doi jvi chuang i et al dna primeadenovirus boost malaria vaccine encoding p falciparum csp and ama induces sterile protection associated with cellmediated immunity plos one  feb e doi journalpone kharfandabaja ma et al reanalysis of transvax immunogenicity lancet infect dis  jan doi s  raviprakash k et al a dengue dna vaccine formulated with vaxfectin® is well tolerated and elicits strong neutralizing antibody responses to all four dengue serotypes in new zealand white rabbits hum vaccin immunother  dec  doi hv epub  oct  doukas j rolland a mechanisms of action underlying the immunotherapeutic activity of allovectin in advanced melanoma cancer gene ther  dec doi cgt epub  oct  review hartikka j et al preclinical evaluation of the immunogenicity and safety of plasmid dnabased prophylactic vaccines for human cytomegalovirus hum vaccin immunother  nov  doi hv epub  aug  richie tl et al clinical trial in healthy malarianaïve adults to evaluate the safety tolerability immunogenicity and efficacy of mustdo a fivegene sporozoitehepatic stage plasmodium falciparum dna vaccine combined with escalating dose human gmcsf dna immunotherapy  nov   doi hv epub  nov  veselenak rl et al a vaxfectin®adjuvanted hsv plasmid dna vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes vaccine  nov   doi jvaccine epub  oct  shlapobersky m et al vaxfectinadjuvanted plasmid dna vaccine improves protection and immunogenicity in a murine model of genital herpes infection j gen virol  junpt  doi vir epub  mar  kharfandabaja ma et al a novel therapeutic cytomegalovirus dna vaccine in allogeneic haemopoietic stemcell transplantation a randomised doubleblind placebocontrolled phase  trial lancet infect dis  apr doi s epub  jan  erratum in lancet infect dis  apr  doukas j et al nonclinical biodistribution integration and toxicology evaluations of an hn pandemic influenza plasmid dna vaccine formulated with vaxfectin® vaccine  jul  doi jvaccine epub  jun  ledgerwood j et al a west nile virus dna vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase i clinical trial j infect dis    chowdhery r gonzalez r immunologic therapy targeting metastatic melanoma allovectin® immunotherapy    sullivan s et al vaxfectin a versatile adjuvant for plasmid dna and proteinbased vaccines expert opin drug del    bedikian ay et al a phase  study of highdose allovectin in patients with advanced metastatic melanoma melanoma res    sedegah m et al vaxfectin® enhances both antibody and in vitro t cell responses to each component of a gene plasmodium falciparum plasmid dna vaccine mixture administered at low doses vaccine    smith lr et al phase  clinical trials of the safety and immunogenicity of adjuvanted plasmid dna vaccines encoding influenza a virus h hemagglutinin vaccine    soares hp lutzky j velimogene aliplasmid exp opin biol ther     hartikka j et al vaxfectin® a cationic lipidbased adjuvant for proteinbased influenza vaccines vaccine    moss rb prospects for control of emerging infectious diseases with plasmid dna vaccines j imm based ther vacc    muller wj et al herpes simplex virus type  tegument proteins contain subdominant tcell epitopes detectable in balbc mice after dna immunization and infection j gen virol    schleiss m vclcb an injectable bivalent plasmid dna vaccine for potential protection against cmv disease and infection curr opin mol ther    shlapobersky m et al vaxfectin®adjuvanted seasonal influenza protein vaccine correlation of systemic and local immunological markers with formulation parameters vaccine    vilalta a et al analysis of biomarkers after intramuscular injection of vaxfectin®formulated hcmv gb plasmid dna vaccine    ye m et al rapid development of a vaxfectin®adjuvanted dna vaccine encoding pandemic swineorigin influenza a virus hn hemagglutinin gene ther reg     bedikian ay del vecchio m allovectin therapy in metastatic melanoma exp opin biol ther    dery m bausch dg a dna vaccine for the prevention of ebola virus infection curr opin mol ther    go v pollard rb a cytomegalovirus vaccine for transplantation are we closer j infect dis    hartikka j et al physical characterization and in vivo evaluation of poloxamerbased dna vaccine formulations j gene med    horton h lalor p rolland a il plasmid electroporation from preclinical studies to phase i clinical trial methods mol biol    lalor pa et al plasmid dnabased vaccines protect mice and ferrets against lethal challenge with avietnam hn influenza virus j infect dis    mahajan r et al a taqman® reverse transcription polymerase chain reaction rtpcr in vitro potency assay for plasmidbased vaccine products mol biotechnol    martin je et al a sars dna vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a phase i clinical trial vaccine    pan ch et al use of vaxfectin adjuvant with dna vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus clin vaccine immunol    wloch mk et al safety and immunogenicity of a bivalent cytomegalovirus dna vaccine in healthy adult subjects j infect dis     abai am et al novel microneutralization assay for hcmv using automated data collection and analysis j immunol methods    jiang g et al induction of multiantigen multistage immune responses against plasmodium falciparum in rhesus monkeys in the absence of antigen interference with heterologous dna primepoxvirus boost immunization malar j    jimenez gs et al vaxfectin™formulated influenza dna vaccines encoding np and m viral proteins protect mice against lethal viral challenge hum vaccin    kaslow dc biological feasibility of developing prophylactic vaccines for viral pathogens incubation period as a critical parameter hum vaccin    martin je et al a west nile virus dna vaccine induces neutralizing antibody in healthy adults during a phase  clinical trial j infect dis    sandbulte mr et al crossreactive neuraminidase antibodies afford partial protection against hn in mice and are present in unexposed humans plos med   e selinsky c et al qualification and performance characteristics of a quantitative enzymelinked immunosorbent assay for human igg antibodies to anthrax lethal factor antigen biologicals    tompkins sm et al matrix protein  vaccination and protection against influenza viruses including subtype hn emerg infect dis    vilalta a et al vaccination with polymerase chain reactiongenerated linear expression cassettes protects mice against lethal influenza a challenge hum gene ther     dunachie sj et al a dna primemodified vaccinia virus ankara boost vaccine encoding thrombospondinrelated adhesion protein but not circumsporozoite protein partially protects healthy malarianaive adults against plasmodium falciparum sporozoite challenge infect immun    gonzalez r et al phase  trial of allovectin in advanced metastatic melanoma melanoma res    hahn uk aichler m boehm r beyer w comparison of the immunological memory after dna vaccination and protein vaccination against anthrax in sheep vaccine    leamy vl et al comparison of rabbit and mouse models for persistence analysis of plasmidbased vaccines hum vaccin    margalith m vilalta a sustained protective rabies neutralizing antibody titers after administration of cationic lipidformulated pdna vaccine genet vaccines ther    minke jm et al use of dna and recombinant canarypox viral alvac vectors for equine herpes virus vaccination vet immunol immunopathol    rolland a nuclear gene delivery the trojan horse approach expert opin drug deliv    romano m et al priming but not boosting with plasmid dna encoding mycolyltransferase aga from mycobacterium tuberculosis increases the survival time of mycobacterium bovis bcg vaccinated mice against low dose intravenous challenge with m tuberculosis hrv vaccine    sedegah m et al vaxfectin enhances immunogenicity and protective efficacy of p yoelii circumsporozoite dna vaccines vaccine     hirschlerner d et al effect of helper lipid on lipoplex electrostatics biochim biophys acta    manthorpe m et al plasmid vaccines and therapeutics from design to applications adv biochem eng biotechnol    rolland a gene medicines the end of the beginning adv drug deliv rev    selinsky c et al a dnabased vaccine for the prevention of human cytomegalovirusassociated diseases hum vaccin    vilalta a et al i poloxamerformulated plasmid dnabased human cytomegalovirus vaccine evaluation of plasmid dna biodistributionpersistence and integration hum gene ther    vilalta a et al ii cationic lipidformulated plasmid dnabased bacillus anthracis vaccine evaluation of plasmid dna persistence and integration potential hum gene ther    yanagie h eriguchi m gene therapy for liver metastasis of colon cancer nippon rinsho   suppl    arpicco s et al synthesis characterization and transfection activity of new saturated and unsaturated cationic lipids farmaco    evans tg et al longterm memory bcell responses in recipients of candidate human immunodeficiency virus type  vaccines vaccine    ferrari me hermanson g rolland a development of anthrax dna vaccines curr opin mol ther    galanis e et al intratumoral administration of a dimyristyloxypropyldimethylhydroxyethyl ammonium bromidedioleoylphosphatidylethanolamine formulation of the human interleukin gene in the treatment of metastatic renal cell carcinoma cancer    geall aj et al targeting malaria with polyamines bioconjug chem    hermanson g et al a cationic lipidformulated plasmid dna vaccine confers sustained antibodymediated protection against aerosolized anthrax spores proc natl acad sci usa    kaslow dc a potential disruptive technology in vaccine development genebased vaccines and their application to infectious diseases trans r soc trop med hyg    li j et al the immunoregulation of mice by somatic transgenic expression of porcine interleukin gene and cpg sequence vet res commun    li x et al modulation of immune response to plasmodium falciparum apical membrane antigen  dna vaccine by cytokine plasmids zhongguo ji sheng chong xue yu ji sheng chong bing za zhi    locher cp witt sa ashlock bm levy ja evaluation of genetic immunization adjuvants to improve the effectiveness of a human immunodeficiency virus type  hiv envelope dna vaccine dna cell biol     bergen m chen r gonzalez r efficacy and safety of hlabbeta microglobulin plasmid dnalipid complex allovectin® in patients with metastatic melanoma expert opin biol ther    coker c majid m radulovic s development of rickettsia prowazekii dna vaccine cloning strategies ann n y acad sci    dai b et al analysis of cpg motifs in endoflagellar gene flab and expression vector vr of leptospiral dna vaccine sichuan da xue xue bao yi xue ban    dumonteil e maria jesus rs javier eo maria del rosario gm dna vaccines induce partial protection against leishmania mexicana vaccine    fischer l et al rabies dna vaccine in the horse strategies to improve serological responses vaccine    fischer l et al vaccination of puppies with a lipidformulated plasmid vaccine protects against a severe canine distemper virus challenge vaccine    glazyrin al kanmitchell j mitchell ml analysis of in vitro immunization generation of cytotoxic tlymphocytes against allogeneic melanoma cells with tumor lysateloaded or tumor rnatransfected antigenpresenting cells cancer immunol immunother    hellum m et al photochemically enhanced gene delivery with cationic lipid formulations photochem photobiol sci    nukuzuma c ajiro n wheeler cj konishi e enhancing effect of vaxfectin on the ability of a japanese encephalitis dna vaccine to induce neutralizing antibody in mice viral immunol    rainczuk a scorza t smooker pm spithill tw induction of specific tcell responses opsonizing antibodies and protection against plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory dna vectors infect immun    rainczuk a et al the protective efficacy of msp against lethal plasmodium chabaudi adami challenge is dependent on the type of dna vaccine vector and vaccination protocol vaccine    rath a et al characterization of immune response in mice to plasmid dna encoding dog zona pellucida glycoprotein vaccine     dsouza s et al improved tuberculosis dna vaccines by formulation in cationic lipids infect immun    ferrari me rusalov d enas j wheeler cj synergy between cationic lipid and colipid determines the macroscopic structure and transfection activity of lipoplexes nucleic acids res    galanis e technology evaluation allovectin vical curr opin mol ther    gaucheron j santaella c vierling p transfection with fluorinated lipoplexes based on fluorinated analogues of dotma dmrie and dppes biochim biophys acta    hogset a et al photochemical transfection a technology for efficient lightdirected gene delivery somat cell mol genet    hong ys et al localized immunosuppression in the cardiac allograft induced by a new liposomemediated il gene therapy j heart lung transplant    kaslow dc transmissionblocking vaccines chem immunol    ota t maeda m tatsuka m cationic liposomes with plasmid dna influence cancer metastatic capability anticancer res    prasmickaite l hogset a berg k the role of the cell cycle on the efficiency of photochemical gene transfection biochim biophys acta    rath a et al antibodies generated in response to plasmid dna encoding zona pellucida glycoproteinb inhibit in vitro human spermegg binding mol reprod dev    sankar v et al salivary gland delivery of pdnacationic lipoplexes elicits systemic immune responses oral dis    seki m iwakawa j cheng h cheng pw p and ptenmmactep gene therapy of human prostate pc carcinoma xenograft using transferrinfacilitated lipofection gene delivery strategy hum gene ther    singh g parker s hobart p the development of a bicistronic plasmid dna vaccine for bcell lymphoma vaccine    timmerman jm et al immunogenicity of a plasmid dna vaccine encoding chimeric idiotype in patients with bcell lymphoma cancer res    uchida e mizuguchi h ishiiwatabe a hayakawa t comparison of the efficiency and safety of nonviral vectormediated gene transfer into a wide range of human cells biol pharm bull    vellon l et al enhanced uptake of antisense oligonucleotides using cationic liposomes and the apoptotic effect of idarubicin in k cell line leuk res    vilalta a whitlow v martin t realtime pcr determination of escherichia coli genomic dna contamination in plasmid preparations anal biochem    zhang t tsang tc harris dt comparison of cis and trans tat gene expression in hiv ltrbased amplifier vectors biotechniques     baccaglini l et al cationic liposomemediated gene transfer to rat salivary epithelial cells in vitro and in vivo j gene med    belldegrun a et al interleukin  gene therapy for prostate cancer phase i clinical trial and basic biology hum gene ther    daniels ga galanis e immunotherapy of renal cell carcinoma by intratumoral administration of an il cdnadmriedope lipid complex curr opin mol ther    ferrari me rusalov d enas j wheeler cj trends in lipoplex physical properties dependent on cationic lipid structure vehicle and complexation procedure do not correlate with biological activity nucleic acids res    fleeton mn et al selfreplicative rna vaccines elicit protection against influenza a virus respiratory syncytial virus and a tickborne encephalitis virus j infect dis    gebhart cl kabanov av evaluation of polyplexes as gene transfer agents j control release    gleich ll et al clinical experience with hlab plasmid dnalipid complex in advanced squamous cell carcinoma of the head and neck arch otolaryngol head neck surg    hartikka j et al electroporationfacilitated delivery of plasmid dna in skeletal muscle plasmid dependence of muscle damage and effect of poloxamer  mol ther    hartikka j et al vaxfectin enhances the humoral immune response to plasmid dnaencoded antigens vaccine    kaiser s toborek m liposomemediated highefficiency transfection of human endothelial cells j vasc res    kaushik a leuvectin vical inc curr opin investig drugs    madry h reszka r bohlender j wagner j efficacy of cationic liposomemediated gene transfer to mesangial cells in vitro and in vivo j mol med    parker se et al safety of a gmcsf adjuvantplasmid dna malaria vaccine gene ther    pleyer u et al efficiency and toxicity of liposomemediated gene transfer to corneal endothelial cells exp eye res    pupa sm et al prevention of spontaneous neuexpressing mammary tumor development in mice transgenic for rat protoneu by dna vaccination gene ther    reyes l et al vaxfectin enhances antigen specific antibody titers and maintains th type immune responses to plasmid dna immunization vaccine    sanchez gi et al immunogenicity and protective efficacy of a plasmodium yoelii hsp dna vaccine in balbc mice infect immun    schleef rr olman ma miles la chuang jl modulating the fibrinolytic system of peripheral blood mononuclear cells with adenovirus hum gene ther    scholl fg et al effects of human tissue plasminogen gene transfer on allograft coronary atherosclerosis j heart lung transplant    simberg d et al phase behavior dna ordering and size instability of cationic lipoplexes relevance to optimal transfection activity j biol chem    stopeck at et al phase ii study of direct intralesional gene transfer of allovectin an hlabbetamicroglobulin dnaliposome complex in patients with metastatic melanoma clin cancer res    suzuki s et al liposomemediated gene therapy using hsvtkganciclovir under the control of human psa promoter in prostate cancer cells urol int    ushijima k et al antihiv activity of an antisense phosphorothioate oligonucleotide bearing imidazole and primary amine groups bioorg med chem    vilalta a wu d margalith m hobart p rabbit epo gene and cdna expression of rabbit epo after intramuscular injection of pdna biochem biophys res commun    yonezawa t et al detection of transgene in progeny at different developmental stages following testismediated gene transfer mol reprod dev     abulhassan k walmsley r boulton m optimization of nonviral gene transfer to human primary retinal pigment epithelial cells curr eye res    aujame l seguin d droy c hessler c experimental design optimization of filamentous phage transfection into mammalian cells by cationic lipids biotechniques      passim blanton jr jr et al plasmid transfection and retroviral transduction of porcine muscle cells for cellmediated gene transfer j anim sci    clark pr stopeck at parker se hersh em cationic lipid gene transfer of an il transgene leads to activation of natural killer cells in a scid mouse human tumor xenograft cell immunol    clark pr et al studies of direct intratumoral gene transfer using cationic lipidcomplexed plasmid dna cancer gene ther    clayton j middlebrook jl vaccination of mice with dna encoding a large fragment of botulinum neurotoxin serotype a vaccine    dai b et al protection against leptospirosis by immunization with plasmid dna encoding  kda endoflagellin of l interrogans serovar lai chin med sci j    dassow h lassner d remke h preiss r modulation of multidrug resistance in human leukemia cells with mdrtargeted antisense oligonucleotides using variable treatment schedules int j clin pharmacol ther    dumonteil e et al comparative study of dna vaccines encoding various antigens against leishmania mexicana dev biol basel    gleich ll gene therapy for head and neck cancer laryngoscope    gutheil jc novel immunologic and biologic therapies for breast cancer curr oncol rep    gutheil jc et al targeted antiangiogenic therapy for cancer using vitaxin a humanized monoclonal antibody to the integrin alphavbeta clin cancer res    hartikka j et al sodium phosphate enhances plasmid dna expression in vivo gene ther    hoffman dm figlin ra intratumoral interleukin  for renalcell carcinoma by direct gene transfer of a plasmid dnadmriedope lipid complex world j urol    horiguchi y et al intravesical liposomemediated interleukin gene therapy in orthotopic murine bladder cancer model gene ther    kunitomi m et al selective inhibition of hepatoma cells using diphtheria toxin a under the control of the promoterenhancer region of the human alphafetoprotein gene jpn j cancer res    larchian wa et al effectiveness of combined interleukin  and b vaccination strategy is dependent on the sequence and order a liposomemediated gene therapy treatment for bladder cancer clin cancer res    le tp et al safety tolerability and humoral immune responses after intramuscular administration of a malaria dna vaccine to healthy adult volunteers vaccine    madry h trippel sb efficient lipidmediated gene transfer to articular chondrocytes gene ther    mizuta t et al inhibitory effects of an antisense oligonucleotide in an experimentally infected mouse model of influenza a virus biochem biophys res commun    norman ja et al dna vaccine encoding psma significantly reduces tumor growth and prolongs life in mice with tramp tumors clinical cancer research    sedegah m et al improving protective immunity induced by dnabased immunization priming with antigen and gmcsfencoding plasmid dna and boosting with antigenexpressing recombinant poxvirus j immunol    takagi t et al effect of cationic liposomes on intracellular trafficking and efficacy of antisense oligonucleotides in mouse peritoneal macrophages j drug target    thompson ja et al phase ii trial of plasmid dnalipid leuvectin immunotherapy in patients with metastatic renal cell carcinoma clinical cancer research    vellon l cuello t gargallo p larripa i antisense oligonucleotides increase the apoptotic effect of idarubicin in k cell line medicina b aires    zelphati o et al pnadependent gene chemistry stable coupling of peptides and oligonucleotides to plasmid dna biotechniques      zhang yy et al immunogenicity of plasmid dna encoding the  kda fragment of schistosoma japonicum myosin vaccine     abai am hobart pm barnhart km insulin delivery with plasmid dna hum gene ther    abai am hobart pm norman j gene therapy for type diabetes diabetes    akporiaye et hersh e clinical aspects of intratumoral gene therapy curr opin mol ther    anderson kl et al pu and the granulocyte and macrophage colonystimulating factor receptors play distinct roles in latestage myeloid cell differentiation blood    barnhart km simplified pcrmediated linkerscanning mutagenesis biotechniques    cameron fh et al a transfection compound series based on a versatile tris linkage biochim biophys acta    chang y prudhomme gj intramuscular administration of expression plasmids encoding interferongamma receptorigg or iligg chimeric proteins protects from autoimmunity j gene med    clayman gl dreiling l local delivery for gene therapy curr oncol rep    fernandes j et al in vivo transfer of interleukin receptor antagonist gene in osteoarthritic rabbit knee joints prevention of osteoarthritis progression am j pathol    figlin ra parker se horton hm technology evaluation interleukin gene therapy for the treatment of renal cell carcinoma curr opin mol ther    galanis e et al immunotherapy of advanced malignancy by direct gene transfer of an interleukin dnadmriedope lipid complex phase iii experience j clin oncol    hasan ua et al nucleic acid immunization concepts and techniques associated with third generation vaccines j immunol methods    hermanson gg singh g hobart p immunogenicity and protective effects of coadministered cytokine and chemokine plasmid dnas in a murine bcell lymphoma model cancer gene therapy    hernandez p hof r parker s horton h systemic treatment of cancer by intramuscular injection of an interferonalphaexpressing plasmid dna cancer gene therapy    hersh e et al longterm followup of melanoma patients who have received allovectin gene therapy treatment cancer gene therapy    horton hm hernandez p parker se barnhart km antitumor effects of interferonomega in vivo therapy of human tumor xenografts in nude mice cancer res    horton hm parker se wloch mk norman ja dna vaccines for cancer therapy expert opin investig drugs    horton hm et al a gene therapy for cancer using intramuscular injection of plasmid dna encoding interferon alpha proc natl acad sci usa    horton hm et al il plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile j immunol    ilan y technology evaluation naked dna curr opin mol ther    kisich ko malone rw feldstein pa erickson kl specific inhibition of macrophage tnfalpha expression by in vivo ribozyme treatment j immunol    klavinskis ls barnfield c gao l parker s intranasal immunization with plasmid dnalipid complexes elicits mucosal immunity in the female genital and rectal tracts j immunol    klinman dm barnhart km conover j cpg motifs as immune adjuvants vaccine    li k stewart dj ward hj technology evaluation gene therapy fgf vical curr opin mol ther    martin t et al plasmid dna malaria vaccine the potential for genomic integration after intramuscular injection hum gene ther    miao j et al humoral immune response in mice to hybrid nucleic acid vaccines containing plasmodium falciparum merozoite surface protein  block based gene zhongguo ji sheng chong xue yu ji sheng chong bing za zhi    neglia f et al dna vaccination against the ovarian carcinomaassociated antigen folate receptor alpha fralpha induces cytotoxic t lymphocyte and antibody responses in mice cancer gene ther    ochiya t et al evaluation of cationic liposome suitable for gene transfer into pregnant animals biochem biophys res commun    oku n delivery of contrast agents for positron emission tomography imaging by liposomes adv drug deliv rev    pal s et al vaccination of mice with dna plasmids coding for the chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge vaccine    parker se et al plasmid dna malaria vaccine tissue distribution and safety studies in mice and rabbits hum gene ther    pereirachioccola vl et al comparison of antibody and protective immune responses against trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked dna or recombinant protein parasite immunol    prudhomme gj chang y prevention of autoimmune diabetes by intramuscular gene therapy with a nonviral vector encoding an interferongamma receptorigg fusion protein gene ther    ramasamy r et al mammalian cell expression of malaria merozoite surface proteins and experimental dna and rna immunisation biochim biophys acta    rini bi selk lm vogelzang nj phase i study of direct intralesional gene transfer of hlab into metastatic renal carcinoma lesions clin cancer res    schreiber a et al effect of leuvectin an interleukin gene therapy agent on prostatespecific antigen psa in patients undergoing neoadjuvant or adjuvant gene therapy for prostate cancer cancer gene therapy    smith gj rd et al fast and accurate method for quantitating e coli hostcell dna contamination in plasmid dna preparations biotechniques      smooker pm et al humoral responses in mice following vaccination with dna encoding glutathione stransferase of fasciola hepatica effects of mode of vaccination and the cellular compartment of antigen expression parasite immunol    wloch mk et al human gp plasmid dna vaccination induces cytotoxic t lymphocytes ctls that lyse interferonalpha ifnalphatreated but not untreated mouse melanoma cells cancer gene therapy    you z et al immunogenicity and immunoprotection of a leptospiral dna vaccine hua xi yi ke da xue xue bao    zelphati o liang xw hobart p felgner pl gene chemistry functionally and conformationally intact fluorescent plasmid dna human gene therapy     anchordoquy tj girouard lg carpenter jf kroll dj stability of lipiddna complexes during agitation and freezethawing j pharm sci    barnhart km et al enhancer and promoter chimeras in plasmids designed for intramuscular injection a comparative in vivo and in vitro study hum gene ther    campain ja et al lipid and adenoviralmediated gene transfer into aidskaposis sarcoma cell lines cancer gene ther    debruyne la et al lipidmediated gene transfer of viral il prolongs vascularized cardiac allograft survival by inhibiting donorspecific cellular and humoral immune responses gene ther    doolan dl et al dna vaccination as an approach to malaria control current status and strategies curr top microbiol immunol    felgner pl rolland a preface adv drug deliv rev    ferrari me et al analytical methods for the characterization of cationic lipidnucleic acid complexes hum gene ther    gleich ll et al alloantigen gene therapy for squamous cell carcinoma of the head and neck results of a phase trial arch otolaryngol head neck surg    hedstrom rc et al in vitro expression and in vivo immunogenicity of plasmodium falciparum preerythrocytic stage dna vaccines int j mol med    hernandez p anderson d parker s horton h a novel plasmid dna gene therapy for treatment of metastatic disease cancer gene therapy   d horton hm et al development of a novel plasmid dna gene therapy for treatment of distant primary and metastatic tumors in mice cancer gene therapy    huang cy et al lipitoidsnovel cationic lipids for cellular delivery of plasmid dna in vitro chem biol    konopka k et al delivery of an antihiv ribozyme into hivinfected cells via cationic liposomes biochim biophys acta    lahijani r et al quantitation of host cell dna contaminate in pharmaceuticalgrade plasmid dna using competitive polymerase chain reaction and enzymelinked immunosorbent assay hum gene ther    mccluskie mj et al direct gene transfer to the respiratory tract of mice with pure plasmid and lipidformulated dna antisense nucleic acid drug dev    murphy je et al a combinatorial approach to the discovery of efficient cationic peptoid reagents for gene delivery proc natl acad sci usa    nabel gj hobart p keystone symposia on molecular and cellular biology of gene therapy and synthetic nonviral gene delivery systems keystone co usa january   biochim biophys acta   r raghupathi r et al bcl overexpression attenuates cortical cell loss after traumatic brain injury in transgenic mice journal of cerebral blood flow and metabolism    rolland a felgner pl nonviral gene delivery systems  preface advanced drug delivery reviews    saffran dc et al immunotherapy of established tumors in mice by intratumoral injection of interleukin plasmid dna induction of cd tcell immunity cancer gene ther    sawai k et al a novel method of cellspecific mrna transfection mol genet metab    sedegah m et al boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria dna vaccine proc natl acad sci usa    stopeck at et al transfection of primary tumor cells and tumor cell lines with plasmid dnalipid complexes cancer gene ther    surovoy a flechsler i jung g a novel series of serumresistant lipoaminoacid compounds for cellular delivery of plasmid dna adv exp med biol    wang r et al induction of antigenspecific cytotoxic t lymphocytes in humans by a malaria dna vaccine science    wang r et al simultaneous induction of multiple antigenspecific cytotoxic t lymphocytes in nonhuman primates by immunization with a mixture of four plasmodium falciparum dna plasmids infect immun    weiss wr et al a plasmid encoding murine granulocytemacrophage colonystimulating factor increases protection conferred by a malaria dna vaccine j immunol    zelphati o et al stable and monodisperse lipoplex formulations for gene delivery gene ther     barnfield c et al characterization of gene expression following intranasal immunization with nucleic acid biochem soc trans   s doh sg et al spatialtemporal patterns of gene expression in mouse skeletal muscle after injection of lacz plasmid dna gene ther    doolan dl et al dna vaccines for malaria the past the present  the future indian j med res    duncan je whitsett ja horowitz ad pulmonary surfactant inhibits cationic liposomemediated gene delivery to respiratory epithelial cells in vitro hum gene ther    eastman sj et al biophysical characterization of cationic lipid dna complexes biochim biophys acta    el ouahabi a et al the role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids febs lett    fasbender a zabner j zeiher bg welsh mj a low rate of cell proliferation and reduced dna uptake limit cationic lipidmediated gene transfer to primary cultures of ciliated human airway epithelia gene ther    felgner jh separation and quantitation of cationic liposome components by high performance liquid chromatography with evaporative lightscattering detection pharm res    felgner pl nonviral strategies for gene therapy sci am    felgner pl et al nomenclature for synthetic gene delivery systems hum gene ther    gao l et al mucosal delivery of nucleic acid elicits both cellular and humoral immunity biochem soc trans   s gramzinski ra et al malaria dna vaccines in aotus monkeys vaccine    hedstrom rc et al the development of a multivalent dna vaccine for malaria springer semin immunopathol    hersh em stopeck at advances in the biological therapy and gene therapy of malignant disease clin cancer res    hersh em stopeck at recent advances in the treatment of malignant melanoma with gene therapy mol med    hersh em et al phase ii study of intratumoral injection of hlabbeta m plasmid dnacationic lipid complex allovectin therapy for metastatic malignant melanoma mmm cancer gene therapy    hoffman sl et al strategy for development of a preerythrocytic plasmodium falciparum dna vaccine for human use vaccine    hoffman sl et al toward clinical trials of dna vaccines against malaria immunol cell biol    horton h et al gene therapy of ovarian cancer via il plasmid dna and cationic lipid cancer gene therapy    hsiao m et al intracavitary liposomemediated p gene transfer into glioblastoma with endogenous wildtype p in vivo results in tumor suppression and longterm survival biochem biophys res commun    klavinskis ls et al mucosal immunization with dnaliposome complexes vaccine    kochel t et al inoculation of plasmids expressing the dengue envelope gene elicit neutralizing antibodies in mice vaccine    konopka k harrison gs felgner pl duzgunes n cationic liposomemediated expression of hivregulated luciferase and diphtheria toxin a genes in hela cells infected with or expressing hiv biochim biophys acta    luke cj carner k liang x barbour ag an ospabased dna vaccine protects mice against infection with borrelia burgdorferi j infect dis    marquet m horn na meek ja characterization of plasmid dna vectors for use in human gene therapy biopharmthe technology  business of biopharmaceuticals    norman ja et al development of improved vectors for dnabased immunization and other gene therapy applications vaccine    parker se ducharme s norman j wheeler cj tissue distribution of the cytofectin component of a plasmiddnacationic lipid complex following intravenous administration in mice hum gene ther    rodman dm et al in vivo gene delivery to the pulmonary circulation in rats transgene distribution and vascular inflammatory response am j respir cell mol biol    rubin j et al phase i study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen hlab gene ther    rubin j et al phase iii trial of the il dnadmriedope lipid complex as an immunotherapeutic agent by direct gene transfer in patients with advanced melanoma renal cell carcinoma and sarcoma cancer gene therapy    snyder ds et al ribozymemediated inhibition of a philadelphia chromosomepositive acute lymphoblastic leukemia cell line expressing the p bcrabl oncogene biol blood marrow transplant    stopeck at et al phase i study of direct gene transfer of an allogeneic histocompatibility antigen hlab in patients with metastatic melanoma j clin oncol    tanner fc carr dp nabel gj nabel eg transfection of human endothelial cells cardiovasc res    teifel m heine lt milbredt s friedl p optimization of transfection of human endothelial cells endothelium    waddill w rd et al human gene therapy for melanoma ctguided interstitial injection ajr am j roentgenol    zuidam nj barenholz y electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by heptadecylhydroxycoumarin biochim biophys acta     bebok z et al efficiency of plasmid delivery and expression after lipidmediated gene transfer to human cells in vitro j pharmacol exp ther    bourne n stanberry lr bernstein di lew d dna immunization against experimental genital herpes simplex virus infection j infect dis    doolan dl et al circumventing genetic restriction of protection against malaria with multigene dna immunization cd cell interferon gamma and nitric oxidedependent immunity j exp med    felgner pl improvements in cationic liposomes for in vivo gene transfer hum gene ther    gardner mj et al dna vaccines against malaria immunogenicity and protection in a rodent model j pharm sci    hartikka j et al an improved plasmid dna expression vector for direct injection into skeletal muscle hum gene ther    konopka k pretzer e felgner pl duzgunes n human immunodeficiency virus type hiv infection increases the sensitivity of macrophages and thp cells to cytotoxicity by cationic liposomes biochim biophys acta    lahijani r et al highyield production of pbrderived plasmids intended for human gene therapy by employing a temperaturecontrollable point mutation hum gene ther    liang x et al novel high expressing and antibioticcontrolled plasmid vectors designed for use in gene therapy gene ther    mccarthy m dna vaccination a direct line to the immune system lancet    nabel gj et al immune response in human melanoma after transfer of an allogeneic class i major histocompatibility complex gene with dnaliposome complexes proc natl acad sci usa    oku n et al effect of serum protein binding on realtime trafficking of liposomes with different charges analyzed by positron emission tomography biochim biophys acta    parker se et al plasmid dna gene therapy studies with the human interleukin gene in tumor cells in vitro and in the murine b melanoma model in vivo cancer gene ther    schwarz la et al delivery of dnacationic liposome complexes by smallparticle aerosol hum gene ther    stephan dj et al a new cationic liposome dna complex enhances the efficiency of arterial gene transfer in vivo hum gene ther    syrengelas ad chen tt levy r dna immunization induces protective immunity against bcell lymphoma nat med    tripathy sk et al longterm expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid dna vector proc natl acad sci usa    wheeler cj et al a novel cationic lipid greatly enhances plasmid dna delivery and expression in mouse lung proc natl acad sci usa    wheeler cj et al converting an alcohol to an amine in a cationic lipid dramatically alters the colipid requirement cellular transfection activity and the ultrastructure of dnacytofectin complexes biochim biophys acta    zhu j et al a continuous intracerebral gene delivery system for in vivo liposomemediated gene therapy gene ther     fasbender aj zabner j welsh mj optimization of cationic lipidmediated gene transfer to airway epithelia am j physiol   l felgner pl zaugg rh norman ja synthetic recombinant dna delivery for cancer therapeutics cancer gene ther    felgner pl et al improved cationic lipid formulations for in vivo gene therapy ann n y acad sci    harrison gs et al optimization of gene transfer using cationic lipids in cell lines and primary human cd and cd hematopoietic cells biotechniques    hoffman sl et al nucleic acid malaria vaccines current status and potential ann n y acad sci    horn na meek ja budahazi g marquet m cancer gene therapy using plasmid dna purification of dna for human clinical trials hum gene ther    lew d et al cancer gene therapy using plasmid dna pharmacokinetic study of dna following injection in mice hum gene ther    logan jj et al cationic lipids for reporter gene and cftr transfer to rat pulmonary epithelium gene ther    marquet m horn na meek ja process development for the manufacture of plasmid dna vectors for use in gene therapy biopharm    mor g et al complexity of the cytokine and antibody response elicited by immunizing mice with plasmodium yoelii circumsporozoite protein plasmid dna j immunol    norman ja et al preclinical pharmacokinetics manufacturing and safety studies supporting a multicenter cancer gene therapy trial hum gene ther    parker se et al cancer gene therapy using plasmid dna safety evaluation in rodents and nonhuman primates hum gene ther    zabner j et al cellular and molecular barriers to gene transfer by a cationic lipid j biol chem     abai a kuwhararundell a margalith m morrow j parker se rhodes gh coinjection of the genes for interlukin and antigen does not increase humoral immune response in norrby e bf chanock rm ginsberg hs ed vaccines  cold spring harbor press cold spring harbor ny  pp  felgner jh et al enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations j biol chem    nabel gj et al immunotherapy for cancer by direct gene transfer into tumors hum gene ther    plautz ge et al direct gene transfer for the understanding and treatment of human disease ann n y acad sci    raz e et al intradermal gene immunization the possible role of dna uptake in the induction of cellular immunity to viruses proc natl acad sci usa    raz e carson da rhodes gh abai am tsai yj wheeler cj morrow j felgner pl baird sm cationic lipids inhibit intradermal genetic vaccination in norrby e bf chanock rm ginsberg hs ed vaccines  cold spring harbor press cold spring harbor ny  pp  rhodes gh et al characterization of humoral immunity after dna injection dev biol stand    schmid s rhodes g morrow j hoffman sl kang as nucleic acid vaccines against the preerythrocytic stage of rodent malaria plasmodium yoelii cold spring harbor symposium october  abstract sedegah m hedstrom r hobart p hoffman sl protection against malaria by immunization with plasmid dna encoding circumsporozoite protein proc natl acad sci usa    sorscher ej et al gene therapy for cystic fibrosis using cationic liposome mediated gene transfer a phase i trial of safety and efficacy in the nasal airway hum gene ther    vahlsing hl et al immunization with plasmid dna using a pneumatic gun j immunol methods    vogelzang nj lestingi tm sudakoff g kradjian sa phase i study of immunotherapy of metastatic renal cell carcinoma by direct gene transfer into metastatic lesions hum gene ther    zhou x et al selfreplicating semliki forest virus rna as recombinant vaccine vaccine     cohen j naked dna points way to vaccines science    duzgunes n felgner pl intracellular delivery of nucleic acids and transcription factors by cationic liposomes methods enzymol    dwarki vj malone rw verma im cationic liposomemediated rna transfection methods enzymol    felgner pl genes in a bottle lab invest    liu m ulmer jb friedman a martinex d hawe la dewitt cm leander kr shi xp montogomery dl donnelly jj parker s felgner p felgner j immunization with dna encoding a conserved internal viral protein results in protection from morbidity and mortality due to challenge with influenza a in mice in ginsberg hs bf chanock rm lerner ra ed vaccines  cold spring harbor press cold spring harbor ny  pp  manthorpe m et al gene therapy by intramuscular injection of plasmid dna studies on firefly luciferase gene expression in mice hum gene ther    nabel gj felgner pl direct gene transfer for immunotherapy and immunization trends biotechnol    nabel gj et al direct gene transfer with dnaliposome complexes in melanoma expression biologic activity and lack of toxicity in humans proc natl acad sci usa    rhodes gh et al injection of expression vectors containing viral genes induces cellular humoral and protective immunity in ginsberg hs ed vaccines  cold spring harbor press cold spring harbor ny  pp  san h et al safety and shortterm toxicity of a novel cationic lipid formulation for human gene therapy hum gene ther    ulmer jb et al heterologous protection against influenza by injection of dna encoding a viral protein science    yankauckas ma et al longterm antinucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid dna containing np gene dna cell biol     jiao s et al persistence of plasmid dna and expression in rat brain cells in vivo exp neurol    kumar r gardner mf richman dd hostetler ky equal inhibition of hiv replication by stereoisomers of phosphatidylazidothymidine lack of stereospecificity of lysosomal phospholipase a j biol chem    nabel eg plautz g nabel gj transduction of a foreign histocompatibility gene into the arterial wall induces vasculitis proc natl acad sci usa     felgner pl rhodes g gene therapeutics nature    king dh fluorinated pyrimidines a new change for old drugs transplant proc     hostetler ky et al synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides j biol chem    wolff ja et al direct gene transfer into mouse muscle in vivo science     duzgunes n goldstein ja friend ds felgner pl fusion of liposomes containing a novel cationic lipid n dioleyloxypropylnnntrimethylammonium induction by multivalent anions and asymmetric fusion with acidic phospholipid vesicles biochemistry    felgner pl ringold gm cationic liposomemediated transfection nature    felgner pl holm m chan h cationic liposome mediated transfection proc west pharmacol soc    malone rw felgner pl verma im cationic liposomemediated rna transfection proc natl acad sci usa     felgner pl et al lipofection a highly efficient lipidmediated dnatransfection procedure proc natl acad sci usa    connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube vaxfectin®publications published scientific articles on vaxfectin® related links pubmed about us overviewcorporate governanceboard of directors board committees managementcareers technology dna technology poloxamer delivery system vaxfectin® adjuvantpublications products pipelineasp therapeutic cmv vaccinecymvectin™ prophylactic cmv vaccinevclhb therapeutic hsv vaccinevl antifungalother products apex®ihndengue vaccineoncept® clinical trials overview  active programs investors overviewstock informationnews releasesevents  presentationssec filings contact us contact infodirections to vicalcareers connect with us rss feeds email alerts linkedin slideshare stocktwits twitter youtube   vical inc privacy policy terms of use site map p     pacific center court san diego california  designed by mentus powered by q inc  this link to a nonvical website is provided as a resource vical assumes no responsibility for content not provided by vical or for practices or standards of any nonvical websites